With the Nasdaq near all-time highs, one analyst says biotechs will lead the index on its next leg higher. And stocks like these 5 could lead the way.
Read MorePlus, jobless claims unexpectedly rose last week, Curevac shares are down after the company said its COVID-19 vaccine was only 47% effective in interim results for a large late-stage trial, and Microsoft CEO Nadella was elected chairman of the company’s board.
Read MorePlus, Regeneron said its antibody cocktail reduced the risk of death by 20% among hospitalized COVID-19 patients, Oracle disappointed on earnings guidance, and Diageo inked a multi-year deal with the NFL.
Read MorePlus, the U.S. and EU resolved their 17-year long Boeing-Airbus trade dispute, GM is partnering with Wabtec to develop and commercialize electric locomotives, and Best Buy is expanding into luggage and outdoor grills.
Read MorePlus, Bitcoin is up on yet another Elon Musk tweet, Novavax said its COVID-19 vaccine was 90% effective overall in a late-stage trial, and American Express is launching its first checking account for small businesses.
Read MorePlus, Tesla began deliveries of its Model S Plaid, Netflix is launching an online shop, and Apple hired a veteran from BMW.
Read MorePlus, GameStop announced a new CEO and CFO, Moderna asked the FDA to expand the approved use of its COVID-19 vaccine to 12 to 17 year olds, and Restoration Hardware delivered an earnings beat.
Read MorePlus, Bitcoin dropped as low as $31,035, Chipotle is raising menu prices as ingredients and labor costs rise, and Ferrari appointed a new CEO.
Read MorePlus, AMC shares are surging again, G-7 finance ministers agreed to enact a 15% minimum global tax rate for corporations, and Tesla cancelled its Model S Plaid Plus vehicle.
Read MoreAs much as everybody is anxious to put the pandemic and COVID-19 concerns and commentary in the rear view, the practical reality is that the aftermath – which includes dealing with ongoing health concerns – will continue to extend through the rest of the year. In the United States, it’s tempting to say that the […]
Read MorePlus, Moderna asked for full approval from the FDA for its COVID-19 vaccine, AMC raised $230 million via a stock sale to Mudrick Capital, and Cloudera is going private.
Read MoreEver since coronavirus found its way to American shores, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. As of this writing, vaccinations have steadily […]
Read MorePlus, Tesla’s Musk said he’s having discussions with Bitcoin miners regarding the coin’s sustainability, Moderna said its COVID-19 vaccine was 100% effective in teens ages 12 to 17, and Square is reportedly gearing up to launch checking and savings accounts.
Read MoreThere is a lot of fundamental data that I rely on to help paint an overall picture about underlying strength of any stock I might consider using for a value-based investment. While some fundamental investors prefer to work with easy-to-reference, quick-glance data like earnings per share, I prefer to expand my view of a company’s […]
Read MorePlus, the national average for gas jumped above $3 per gallon as the Colonial Pipeline remains mostly offline, Domino’s Pizza shares jump as Bill Ackman revealed 6% stake in the chain, and Wendy’s delivered an earnings beat.
Read More